|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.2299 - 0.2496|
|52 Week Range||0.0610 - 0.2500|
|Beta (5Y Monthly)||0.33|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CHICAGO, Aug. 5, 2019 /PRNewswire/ -- Veltex Corporation – OTC Markets symbol (VLXC) Veltex Corporation ("Veltex") announces the appointment of Luba Andrus, RPh., M.J. to the Board of Directors. Luba Andrus has more than 30 years of executive, operational, and retail leadership experience in both the pharmaceutical and cannabis industries, including owning co-founder and principal of two medical marijuana dispensaries in Illinois. Prior to entering the medical cannabis industry, she owned and operated numerous retail pharmacies which were ultimately sold to a Resurrection hospital system.
CHICAGO, May 13, 2019 /PRNewswire/ -- Veltex Corporation-- OTC Markets symbol (VLXC) Veltex Corporation announces the 33rd Annual Meeting of Shareholders will be held on Thursday July 25, 2019 at The Wynn Hotel and Resort in Las Vegas, Nevada. The property is located at 3131 South Las Vegas Boulevard, Las Vegas, Nevada 89109, USA Telephone 1-702-770-7000. Only shareholders of record may attend the Annual Meeting.
CHICAGO, April 23, 2019 /PRNewswire/ -- Veltex Corporation -- OTC Markets symbol (VLXC) Veltex Corporation ("Veltex") announces that Dr. Harry L. Haroutunian, MD has joined the Veltex Board of Directors effective immediately. Veltex President and CEO Andreas Mauritzson commented, "We are very excited to welcome Dr. Haroutunian to our board who is the foremost expert in the field of addiction treatment and brings with him deep knowledge, extensive relationships and a unique approach to recovery. Dr. Haroutunian will be a cornerstone to Veltex's highly anticipated entry into the $25 billion health and wellness business.